国际医药卫生导报2023，Vol.29Issue(24)：3546-3550,5.DOI:10.3760/cma.j.issn.1007-1245.2023.24.005
特应性皮炎的靶向治疗新进展
New progress in targeted therapy for atopic dermatitis
房祥芳 1黄钰洁 1李岩峰 1王忠永1
作者信息
- 1. 滨州医学院附属医院皮肤科,滨州 256600
- 折叠
摘要
Abstract
Atopic dermatitis is a common chronic,recurrent,and inflammatory skin disease,and seriously affects children's growth and development and adults'quality of life.Traditional therapeutic drugs often have many limitations and are not effective for patients with moderate to severe atopic dermatitis.In recent years,the emergence of new targeted drugs such as biologicals and small molecule inhibitors has brought good news to patients with moderate to severe atopic dermatitis.关键词
特应性皮炎/生物制剂/小分子抑制剂/进展Key words
Atopic dermatitis/Biologicals/Small molecule inhibitors/Progress引用本文复制引用
房祥芳,黄钰洁,李岩峰,王忠永..特应性皮炎的靶向治疗新进展[J].国际医药卫生导报,2023,29(24):3546-3550,5.
